NCT04859569 2021-06-07Efficacy and Safety of LY01011 and Xgeva® in Patients With Bone Metastases From Solid TumorsLuye Pharma Group Ltd.Phase 3 Unknown850 enrolled
NCT04494373 2020-08-04Comparing of the Pharmacokinetic, Pharmacodynamic, Safety and Immunogenicity of HS-20090 and Xgeva® in Healthy AdultsJiangsu Hansoh Pharmaceutical Co., Ltd.Phase 1 Unknown154 enrolled